2009
DOI: 10.1016/j.schres.2009.03.001
|View full text |Cite
|
Sign up to set email alerts
|

Basic symptoms in the general population and in psychotic and non-psychotic psychiatric adolescents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
20
0
4

Year Published

2010
2010
2017
2017

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 42 publications
(27 citation statements)
references
References 17 publications
3
20
0
4
Order By: Relevance
“…Participants included adolescents with a schizophrenia spectrum disorder receiving their first treatment of psychosis in one of the seven adolescent psychiatric sites in Switzerland and Germany (VESPA group) (Meng et al, 2009) They were enrolled based on the following inclusion criteria: age of 14 to 18 years, antipsychotic treatment of 4 weeks or less, and living with a parent or guardian for at least 3 months before admission. Forty-two adolescents fulfilled the inclusion criteria.…”
Section: Participantsmentioning
confidence: 99%
“…Participants included adolescents with a schizophrenia spectrum disorder receiving their first treatment of psychosis in one of the seven adolescent psychiatric sites in Switzerland and Germany (VESPA group) (Meng et al, 2009) They were enrolled based on the following inclusion criteria: age of 14 to 18 years, antipsychotic treatment of 4 weeks or less, and living with a parent or guardian for at least 3 months before admission. Forty-two adolescents fulfilled the inclusion criteria.…”
Section: Participantsmentioning
confidence: 99%
“…They can lead to delays in the maturation of neuropsychological functions in affected children and adolescents and longterm neuropsychological deficits [1,2] as well as significant impairments in psychosocial functioning [3]. This makes schizophrenia one of the six leading causes of years lived with disability [4].…”
mentioning
confidence: 99%
“…This question came into focus with several studies in adults and children that report high rates of standardized lay person or self-report assessed psychotic-like experiences in the general population [15]. However, only three studies addressed this question to date in adults [22] and adolescents [3,23] using appropriate clinical assessments of atrisk criteria. All the three studies found rather low rates of APS or BLIPS in children (age 11-13; 0.9-8.1 % depending on UHR definition [23]) or adults (age 16-40; 0-2 % [22]) as well as COPER (\3 %) and COGDIS (\8.0 %) in adolescents [13].…”
mentioning
confidence: 99%
“…Además, son escasas las investigaciones que estudian prevención e intervención de las psicosis de inicio precoz en población infanto-juvenil (<18 años). 26,27 De modo relevante, el German-Austrian-Swiss multicenter study (VESPA) 28 encontró que la prevalencia de los SB en una muestra de adolescentes de la población general es alta (30.2%), aumentando a 81% en la muestra de adolescentes con trastornos psiquiátricos no psicóticos y hasta el 96.5% en los casos con psicosis de inicio precoz. Todo lo anterior, más la ausencia de una herramienta clínica de riesgo de psicosis diseñada para este grupo de edad, puede suponer que se desatiendan importantes aspectos diferenciales de la población infantil y adolescente.…”
Section: Evaluación De Los Síntomas Básicosunclassified